HIGHLANDS BANKSHARES, INC. (OTCMKTS:HLND) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

HIGHLANDS BANKSHARES, INC. (OTCMKTS:HLND) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

HIGHLANDS BANKSHARES, INC. (OTCMKTS:HLND) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 1, 2019, Edward M. Rosinus resigned as a director […]

The post HIGHLANDS BANKSHARES, INC. (OTCMKTS:HLND) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers appeared first on Market Exclusive.

OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files An 8-K Entry into a Material Definitive Agreement

OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files An 8-K Entry into a Material Definitive Agreement

OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 On June 3 2019, OncBioMune Pharmaceuticals, Inc. (the “Company”) entered into Securities Purchase Agreements (each, an “SPA”) with a group of investors (the “Investors”) to purchase a series of convertible notes (the “Notes”) and accompanying warrants (the “Warrants”) for an aggregate […]

The post OncBioMune Pharmaceuticals, Inc. (OTCMKTS:OBMP) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive.

PREMIER BIOMEDICAL, INC. (OTCMKTS:BIEI) Files An 8-K Regulation FD Disclosure

PREMIER BIOMEDICAL, INC. (OTCMKTS:BIEI) Files An 8-K Regulation FD Disclosure

PREMIER BIOMEDICAL, INC. (OTCMKTS:BIEI) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure. On July 30, 2019, we issued a press release disclosing our joint venture agreement with New Earth Development, RushNet Inc., and XYZ Hemp, Inc. In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current […]

The post PREMIER BIOMEDICAL, INC. (OTCMKTS:BIEI) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

ValueSetters, Inc. (OTCMKTS:VSTR) Files An 8-K Regulation FD Disclosure

ValueSetters,     Inc. (OTCMKTS:VSTR) Files An 8-K Regulation FD Disclosure

ValueSetters, Inc. (OTCMKTS:VSTR) Files An 8-K Regulation FD DisclosureITEM 7.01    Regulation FD Disclosure. The executive officers of ValueSetters, Inc. intend to use the material filed herewith, in whole or in part, in one or more meetings and for a shareholder conference call scheduled for August 7, 2019. A copy of the slide presentation is posted on […]

The post ValueSetters, Inc. (OTCMKTS:VSTR) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

Non-Invasive Monitoring Systems, Inc. (OTCMKTS:NIMU) Files An 8-K Termination of a Material Definitive Agreement

Non-Invasive Monitoring Systems, Inc. (OTCMKTS:NIMU) Files An 8-K Termination of a Material Definitive Agreement

Non-Invasive Monitoring Systems, Inc. (OTCMKTS:NIMU) Files An 8-K Termination of a Material Definitive AgreementITEM 1.02 As previously reported, on December 3, 2018, Non-Invasive Monitoring Systems, Inc., a Florida corporation (the “Company”), entered into an Equity Exchange Agreement (the “Exchange Agreement”) with IRA Financial Trust Company, a South Dakota trust corporation (“IRA Trust”), IRA Financial Group […]

The post Non-Invasive Monitoring Systems, Inc. (OTCMKTS:NIMU) Files An 8-K Termination of a Material Definitive Agreement appeared first on Market Exclusive.

ARCH THERAPEUTICS, INC. (OTCMKTS:ARTH) Files An 8-K Regulation FD Disclosure

ARCH THERAPEUTICS, INC. (OTCMKTS:ARTH) Files An 8-K Regulation FD Disclosure

ARCH THERAPEUTICS, INC. (OTCMKTS:ARTH) Files An 8-K Regulation FD DisclosureItem 7.01 On August 5, 2019, Arch Therapeutics, Inc. (the “Company”) issued a press release that announced the results of two studies conducted to assess the antimicrobial properties of the Company’s AC5TM self-assembling peptide technology platform (AC5), and provided an update on the status of the […]

The post ARCH THERAPEUTICS, INC. (OTCMKTS:ARTH) Files An 8-K Regulation FD Disclosure appeared first on Market Exclusive.

ACQUIRED SALES CORP. (OTCMKTS:AQSP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

ACQUIRED SALES CORP. (OTCMKTS:AQSP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

ACQUIRED SALES CORP. (OTCMKTS:AQSP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On July 30, 2019, the Company filed a certificate of designation of the relative rights and preferences of the Series B convertible preferred stock of […]

The post ACQUIRED SALES CORP. (OTCMKTS:AQSP) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year appeared first on Market Exclusive.

BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant On July 29, 2019, BioLargo, Inc. (the “Company”) closed a private securities offering through […]

The post BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant appeared first on Market Exclusive.

NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Files An 8-K Entry into a Material Definitive Agreement

NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Files An 8-K Entry into a Material Definitive Agreement

NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement Nanophase Technologies Corporation (the “Company”) entered into a Joint Development Agreement, effective as of July 31, 2019 (the “JDA”), with Sumitomo Corporation of Americas (“SCOA”). to the JDA, the Company has agreed, on an exclusive […]

The post NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive.